Add to that MSB has been pulling in some ok % increase sales of TEMCELL in Japan and once GVHD is approved in the USA then I think in another 12 months time we can assume quarterly sales revenue of 4-8 million.
In other words enough to fund the company and start to save cash just from that product alone.
That doesn't supposed a 1billion dollar valuation though so hopefully other trials continue well. I'm just mentioning that if the other trials get good readouts then we are for sure a revenue positive company in another 12 months from today.
Coupled with good LVAD readout I think that definitely would indicate a 3-4billion valuation to be fair.
Ann: End-Stage HF Results Selected For AHA Scientific Sessions, page-54
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |